Jeff Leiden is chairman, president and CEO of Vertex Pharmaceuticals. His conversation with Nature Biotechnology covers rebuilding Vertex toward cystic fibrosis, competing for talent in the innovation economy and dropping out of high school to enter college early. http://www.nature.com/nbt/podcast/index.html.
Rights and permissions
About this article
Cite this article
First Rounders podcast: Jeffrey Leiden. Nat Biotechnol 36, 224 (2018). https://doi.org/10.1038/nbt.4087
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4087